| furosemide / Generic mfg. |
NCT00652652: Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS |
|
|
| Completed | 4 | | US | nesiritide, furosemide | Scios, Inc. | Congestive Heart Failure, Chronic Heart Failure | | 01/04 | | |
| Completed | 4 | 142 | Europe | Torasemide Prolonged Release, Torasemide Prolonged release:Sutril neo, Furosemide, Furosemide: Seguril | Ferrer Internacional S.A. | Congestive Heart Failure | 06/09 | 06/09 | | |
NCT00806910: Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion |
|
|
| Withdrawn | 4 | 0 | US | Conivaptan, Vaprisol, Placebo, Saline | Albert Einstein Healthcare Network, Astellas Pharma Inc | Heart Failure | 02/10 | 02/10 | | |
NCT01549158 / 2011-000972-32: Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure |
|
|
| Terminated | 4 | 8 | Europe | torasemide-PR, Furosemide-IR, torasemide-IR | Ferrer Internacional S.A. | Compensated Heart Failure | 10/12 | 12/12 | | |
| Completed | 4 | 33 | US | Tolvaptan, Samsca, Furosemide, Lasix | University of Southern California, Otsuka America Pharmaceutical | Heart Failure | 02/18 | 03/18 | | |
2019-004292-40: Goal directed fluid removal in critically ill patients with fluid overload. Målrettet behandling af væskeophobning hos patienter på intensiv afdeling. |
|
|
| Ongoing | 4 | 1041 | Europe | Furosemide, Infusion | Department of Anesthesia and Intensive Care Medicine, Nordsjællands hospital, Novo Nordisk Foundation, Jakob Madsens and Hustru Olga Madsens foundation | Treatment of fluid overload in critically ill adult patients in intensive care unit., Treatment of excess fluid in the body in critically ill adults admitted to an intensive care unit., Not possible to specify | | | | |
| Recruiting | 4 | 80 | US | Furosemide, Lasix, Torsemide, Demadex, Bumetanide, Bumex, sacubitril/valsartan, Entresto, Hydralazine, Apresoline, Isosorbide Dinitrate, Dilatrate, Isordil | Heart Center Research, LLC, Boston Scientific Corporation | Heart Failure, Congestive | 12/25 | 12/26 | | |
